1995Drug and Therapeutics BulletinRequires access

Who needs nine ACE inhibitors?

Author information unavailable

Open publisher page 10 citations

Abstract

Nine angiotensin-converting enzyme (ACE) inhibitors are now marketed in the UK. The first, captopril, was introduced in 1981.1 Then followed enalapril,2 lisinopril,3 quinapril, perindopril and ramipril4 and, most recently, cilazapril, fosinopril and ▼trandolapril. Their place in the treatment of patients with heart failure5,6 and hypertension7 is now established, and a new indication as part of the treatment of myocardial infarction is increasingly being recognised. In this article we review the ACE inhibitors and ask if all nine are really needed.

About this research paper

What this paper is about

Nine angiotensin-converting enzyme (ACE) inhibitors are now marketed in the UK. The first, captopril, was introduced in 1981.1 Then followed enalapril,2 lisinopril,3 quinapril, perindopril and ramipril4 and, most recently, cilazapril, fosinopril and ▼trandolapril. Their place in the treatment of patients with heart failure5,6 and hypertension7 is now established, and a new indication as part of the treatment of myocardial infarction is increasingly being recognised. In this article we review the ACE inhibitors and ask if all nine are really needed.

Why it matters

OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Nine angiotensin-converting enzyme (ACE) inhibitors are now marketed in the UK. The first, captopril, was introduced in 1981.1 Then followed enalapril,2 lisinopril,3 quinapril, perindopril and ramipril4 and, most recently, cilazapril, fosinopril and ▼trandolapril. Their place in the treatment of patients with heart failure5,6 and hypertension7 is now established, and a new indication as part of the treatment of myocardial infarction is increasingly being recognised. In this article we review the ACE inhibitors and ask if all nine are really needed.

Key concepts: Quinapril, Perindopril, Fosinopril, Enalapril, Trandolapril, Captopril, Lisinopril, ACE inhibitor

Related papers

Back to paper searchBrowse research topicsOriginal source
Who needs nine ACE inhibitors? — Research Paper | ScholarLens